Events

We will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.

We will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.

This webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.

Learn about vaping reforms and how these will impact consumers, suppliers and health professionals.

We provided an update on the Australian UDI implementation and a guest speaker presented on the real-world benefits of the UDI adoption in the US healthcare system. See the slides and video.

UDI Webinar 16 – Australian UDI update and guest speakers on the value of UDI for procurement and inventory management in hospitals.

This webinar will address the recent announcement by the TGA that medicines containing psilocybin and MDMA will be classified as Schedule 8 (controlled drug) when prescribed by a psychiatrist.

Understand the key findings of the independent expert report on the risks of intentional self-poisoning with paracetamol and have your questions answered about the TGA’s consultation (starting mid-September) on the possible options for changing access or purchasing controls through the Poisons Standard.

Information session for consumers and health practitioners on proposed changes to the way nicotine is supplied.

Information session for consumers and health practitioners on proposed changes to the way nicotine is supplied.

Webinar presentation, recordings and frequently asked questions to explain the proposed changes to the way nicotine is supplied.

A panel discussion was held in Sydney to talk about BIA-ALCL and breast reconstructive surgery. The recording of this discussion is below.

A panel discussion was held in Sydney to talk about BIA-ALCL and breast augmentations. The recording of this discussion is below.